Search
for
Sort by
Research 571–600 of 1000+
- Comprehensive Study of Drug-Induced Pruritus Based on Adverse Drug Reaction Report Database
- Is the Safety of Finasteride Correlated With Its Route of Administration: Topical Versus Oral? A Pharmacovigilance Study With Data From the United States Food and Drug Administration Adverse Event Reporting System
- 43696 Early real-world experience with baricitinib in the treatment of severe alopecia areata
- Inibidores das Janus Associated Kinases na Terapêutica Farmacológica
- The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention
- ODAC Chairs Reveal Challenges, High Drama in a Decade of Service
- Low-Molecular-Weight Synthetic Antioxidants: Classification, Pharmacological Profile, Effectiveness and Trends
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- Dutasteride for the Treatment of Androgenetic Alopecia: An Updated Review
- ADVERSE EFFECTS OF RITLECITINIB IN ADULTS AND ADOLESCENTS WITH ALOPECIA AREATA: A LITERATURE REVIEW
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Reporting on Adverse Clinical Events
- Index of the human papillomavirus (HPV) vaccine industry clinical study programmes and non-industry funded studies: a necessary basis to address reporting bias in a systematic review
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Enhancing the Growth of Natural Eyelashes: The Mechanism of Bimatoprost-Induced Eyelash Growth
- Preparing regenerative therapies for clinical application: proposals for responsible translation
- Patient Profile and Treatment Characteristics of Early Ritlecitinib Initiators in the US
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Alopecia After Switch to Tenofovir Alafenamide in 6 African American Women
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Pharmacovigilance-based drug repurposing: searching for putative drugs with hypohidrosis or anhidrosis adverse events for use against hyperhidrosis
- Bimatoprost for the treatment of eyelash, eyebrow and scalp alopecia
- 5-Alpha-Reductase Inhibitors and Combination Therapy
- Heterogeneity in amount of growth factors secreted by platelets in platelet‐rich plasma samples from alopecia patients
- Artificial hair implantation for hair restoration
- Medicaid coverage of Janus kinase inhibitors for alopecia areata treatment
- Overview of popular cosmeceuticals in dermatology
- Ritlecitinib: First Approval